
233% increase in ROAS
How Mickson Growth increased enterprise lead volume by 310% for Twist Bioscience’s B2B pipeline
Overview
Twist Bioscience is a global synthetic DNA and biotechnology company that powers genomics, drug discovery, and industrial biotech research.
As demand for gene synthesis and DNA data storage solutions expanded, Twist Bioscience needed a smarter digital funnel to convert high-value enterprise traffic into qualified sales inquiries across pharma, academia, and biotech manufacturing.
Visit Site:
https://www.twistbioscience.com/
The problem
Before partnering with Mickson Growth, Twist Bioscience’s paid search and tracking systems were not set up to support their enterprise sales goals:
- Campaigns were not aligned to specific research segments or product lines
- Lead forms weren’t integrated with their CRM for sales follow-up
- No clear attribution between ad spend and demo requests
Their marketing team was spending heavily on traffic that rarely converted into qualified enterprise opportunities. Average CPL exceeded $600, and conversion visibility was minimal.
The solution
Here’s what we did:
- Rebuilt Google Ads and LinkedIn campaigns around specific verticals (pharma, biotech, academia)
- Designed custom landing pages focused on each solution area (synthetic DNA, NGS, biopharma tools)
- Integrated HubSpot and GA4 to capture and attribute enterprise leads accurately
- Implemented account-based remarketing to re-engage key decision makers
- Optimized form flows and CTAs for shorter submission paths
This revamped infrastructure gave Twist Bioscience a fully tracked B2B funnel capable of scaling to enterprise-level deal sizes.
The result
Within 60 days, Twist Bioscience saw a dramatic improvement in lead quality and volume:
- CPL reduced from $600 → $210
- Enterprise lead volume increased by 310%
- Attribution accuracy improved to 98% across sales touchpoints
By pairing data-driven targeting with customized landing experiences, Mickson Growth transformed Twist Bioscience’s digital marketing into a scalable, revenue-aligned pipeline engine for the biotech sector.